[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

December 2019 | 473 pages | ID: I56BEA7A264EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019' provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Immunochemistry Analyzers Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development
3.2 Immunochemistry Analyzers - Pipeline Products by Segment
3.3 Immunochemistry Analyzers - Pipeline Products by Territory
3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path
3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
3.6 Immunochemistry Analyzers - Ongoing Clinical Trials

4 IMMUNOCHEMISTRY ANALYZERS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development

5 IMMUNOCHEMISTRY ANALYZERS COMPANIES AND PRODUCT OVERVIEW

6 IMMUNOCHEMISTRY ANALYZERS- RECENT DEVELOPMENTS

6.1 Nov 12, 2019: New breakthrough in Lyme Disease testing reduces time to results from days to minutes
6.2 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights
6.3 Nov 06, 2019: Meridian submits Curian analyzer and the Curian HpSA assay to the FDA
6.4 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results
6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019
6.6 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI
6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
6.8 Oct 31, 2019: BioTek launches a set of quantitative assay apps to simplify detection-based applications
6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
6.11 Oct 31, 2019: SDI Group: Change of name
6.12 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance
6.13 Oct 30, 2019: Quidel reports third quarter 2019 financial results
6.14 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results
6.15 Oct 30, 2019: Tecan appoints Ralf Griebel a member of the Management Board and Head of Partnering Business
6.16 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials
Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Table 9: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: All-in-One Sensor - Product Status
Table 11: All-in-One Sensor - Product Description
Table 12: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 13: BioLED Device - Diabetes Management - Product Status
Table 14: BioLED Device - Diabetes Management - Product Description
Table 15: ADOR Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: NATlab - Product Status
Table 17: NATlab - Product Description
Table 18: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 19: AgPlus Diagnostic System - Product Status
Table 20: AgPlus Diagnostic System - Product Description
Table 21: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: minDNAnalyzer - Product Status
Table 23: minDNAnalyzer - Product Description
Table 24: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: TruDx 2000 Platform - Product Status
Table 26: TruDx 2000 Platform - Product Description
Table 27: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Clondiag HIV Molecular Device - Product Status
Table 29: Clondiag HIV Molecular Device - Product Description
Table 30: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: BiliNow - Product Status
Table 32: BiliNow - Product Description
Table 33: PKU Now - Product Status
Table 34: PKU Now - Product Description
Table 35: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: ApoStream System - Product Status
Table 37: ApoStream System - Product Description
Table 38: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Point Of Care Diagnostic Device - Phenylketonuria - Product Status
Table 40: Point Of Care Diagnostic Device - Phenylketonuria - Product Description
Table 41: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Atolyzer Consumer Device - Product Status
Table 43: Atolyzer Consumer Device - Product Description
Table 44: Atolyzer Gene - Product Status
Table 45: Atolyzer Gene - Product Description
Table 46: Atolyzer PoC - Product Status
Table 47: Atolyzer PoC - Product Description
Table 48: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: markB - Product Status
Table 50: markB - Product Description
Table 51: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: UniCel DxN - Product Status
Table 53: UniCel DxN - Product Description
Table 54: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview
Table 55: U-PAC - Product Status
Table 56: U-PAC - Product Description
Table 57: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Magnetic Immunoassay Detection System - Product Status
Table 59: Magnetic Immunoassay Detection System - Product Description
Table 60: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: TR-LFIA Diagnostic Analyzer - Product Status
Table 62: TR-LFIA Diagnostic Analyzer - Product Description
Table 63: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: MONITOR System - Product Status

LIST OF FIGURES

Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials

COMPANIES MENTIONED

Access Bio Inc
ADOR Diagnostics Ltd
AgPlus Diagnostics LTD
Akers Biosciences Inc
Akonni Biosystems Inc
Alere Inc
Analytical Diagnostic Solutions Inc
ApoCell Inc
Aptatek BioSciences Inc
Atonomics A/S
BBB Technologies Inc
Beckman Coulter Inc
Binghampton University
Bio-AMD Inc
BioMedomics Inc
Biopico Systems Inc
Biosan Medical Ltd.
Biosensia Ltd
BioSIMS
Boston University
BreviTest Technologies LLC
Brigham and Women's Hospital
Calmark Sweden AB
Canon USA Inc
CardioGenics Inc
Center for Innovation in Point-of-Care Technologies for HIV/AIDS
Cepheid
ChipCare Corp
City, University of London
Clearbridge BioLoc Pte Ltd
Co-Diagnostics Inc
Corgenix Medical Corp
Cornell University
Cutting Edge Medical Devices Limited
Diagnostics For All Inc
DiaSorin SpA
Drew Scientific Co Ltd
Duke University
Dyamed Biotech Pte Ltd
EKF Diagnostics Holdings Plc
Endeavor Sciences Inc
Euroimmun AG
ExcitePCR Corp
Exosome Diagnostics Inc
Fawkes Biotechnology LLC
Firalis SAS
First Light Diagnostics Inc
Florida International University
Future Diagnostics Solutions BV
Genevo Biosystems Pte Ltd
Giner Inc
GlucoSentient Inc
Great Basin Scientific Inc.
HeatFlow Technologies Inc
Indian Institute of Science
Indian Institute of Technology Chennai
Johnson & Johnson
Lucendi Inc
Lucerna Inc
Magellan Diagnostics Inc
Masaryk University
Maxygen-mobile DNA tests
mBio Diagnostics Inc
McKesson Corp
MedNostic Technologies, LLC
Memorial Sloan Kettering Cancer Center
Merck Millipore Corp
Meridian Bioscience Inc
MML Ltd
Molecular Warehouse Ltd
Nalia Systems Ltd
NanoLab Inc
Newcastle University
Nikkiso Co Ltd
Ohmx Corp
OncoGenesis
OncoTherapy Science Inc
Ontera Inc
Ortho-Clinical Diagnostics Inc
Pacific Nanoscience, Inc.
POC Medical Systems Inc
Polymedco CDP, LLC
ProciseDx LLC
Protomex Life Sciences
Quanterix Corp
Qvella Corp
Radisens Diagnostics Ltd
Rapid Diagnostek, Inc.
RMIT University
Sebia SA
SeLux Diagnostics Inc
SenGenix Inc
Spectradyne LLC
StemTek Therapeutics SL
SynderBio Inc
Tecan Group Ltd
The Palo Alto Research Center
Thermal Gradient Inc
Trinity Biotech Plc
Tyncbest Biotechnology
University of Calgary
University of California Berkeley
University of Glasgow
University of Illinois at Chicago
University of Illinois at Urbana-Champaign
University of Michigan Pediatric Device Consortium
University of Pittsburgh
University of South Florida
University of Southern California
Virogenomics BioDevelopment Inc
Wellstat Diagnostics LLC
Xanthostat Diagnostics Inc
Yunnan Energy International Co Ltd


More Publications